Although our results are referred to a larger population, we are not able to confirm that high levels of plasma TGF-β1 represent a possible method of diagnosing NASH in NAFLD patients [20]. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.